A treatable language disorder: Pharmacological treatment of pervasive developmental disorder

Wayne Fisher, Jacob Kerbeshian, Larry Burd

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Results of treatment of four patients are described. All of the patients had pervasive developmental disorder (PDD), a tic disorder, and a characteristic pattern of speech and language impairment. The patients were treated with haloperidol for their tic disorders, and concomitant with the reduction of the frequency and severity of tics was marked improvement in language. The patients averaged 3 months of language gain for each week of speech therapy directly after the initiation of haloperidol treatment for tics. Progress in speech and language therapy was extremely slow during the years prior to treatment with haloperidol. To the authors' knowledge, no language disorder has been described in the literature which shows such a predictable and marked response to pharmacological treatment. The authors hypothesize that tic disorders in individuals with PDD may be a marker for a more positive response to dopamine antagonists like haloperidol.

Original languageEnglish (US)
Pages (from-to)73-76
Number of pages4
JournalJournal of Developmental and Behavioral Pediatrics
Volume7
Issue number2
DOIs
StatePublished - Apr 1986

Fingerprint

Language Disorders
Tic Disorders
Haloperidol
Pharmacology
Speech Therapy
Tics
Language
Language Therapy
Dopamine Antagonists
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this

A treatable language disorder : Pharmacological treatment of pervasive developmental disorder. / Fisher, Wayne; Kerbeshian, Jacob; Burd, Larry.

In: Journal of Developmental and Behavioral Pediatrics, Vol. 7, No. 2, 04.1986, p. 73-76.

Research output: Contribution to journalArticle

@article{49d5ffe3db4e447eb227f5707223eb20,
title = "A treatable language disorder: Pharmacological treatment of pervasive developmental disorder",
abstract = "Results of treatment of four patients are described. All of the patients had pervasive developmental disorder (PDD), a tic disorder, and a characteristic pattern of speech and language impairment. The patients were treated with haloperidol for their tic disorders, and concomitant with the reduction of the frequency and severity of tics was marked improvement in language. The patients averaged 3 months of language gain for each week of speech therapy directly after the initiation of haloperidol treatment for tics. Progress in speech and language therapy was extremely slow during the years prior to treatment with haloperidol. To the authors' knowledge, no language disorder has been described in the literature which shows such a predictable and marked response to pharmacological treatment. The authors hypothesize that tic disorders in individuals with PDD may be a marker for a more positive response to dopamine antagonists like haloperidol.",
author = "Wayne Fisher and Jacob Kerbeshian and Larry Burd",
year = "1986",
month = "4",
doi = "10.1097/00004703-198604000-00001",
language = "English (US)",
volume = "7",
pages = "73--76",
journal = "Journal of Developmental and Behavioral Pediatrics",
issn = "0196-206X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - A treatable language disorder

T2 - Pharmacological treatment of pervasive developmental disorder

AU - Fisher, Wayne

AU - Kerbeshian, Jacob

AU - Burd, Larry

PY - 1986/4

Y1 - 1986/4

N2 - Results of treatment of four patients are described. All of the patients had pervasive developmental disorder (PDD), a tic disorder, and a characteristic pattern of speech and language impairment. The patients were treated with haloperidol for their tic disorders, and concomitant with the reduction of the frequency and severity of tics was marked improvement in language. The patients averaged 3 months of language gain for each week of speech therapy directly after the initiation of haloperidol treatment for tics. Progress in speech and language therapy was extremely slow during the years prior to treatment with haloperidol. To the authors' knowledge, no language disorder has been described in the literature which shows such a predictable and marked response to pharmacological treatment. The authors hypothesize that tic disorders in individuals with PDD may be a marker for a more positive response to dopamine antagonists like haloperidol.

AB - Results of treatment of four patients are described. All of the patients had pervasive developmental disorder (PDD), a tic disorder, and a characteristic pattern of speech and language impairment. The patients were treated with haloperidol for their tic disorders, and concomitant with the reduction of the frequency and severity of tics was marked improvement in language. The patients averaged 3 months of language gain for each week of speech therapy directly after the initiation of haloperidol treatment for tics. Progress in speech and language therapy was extremely slow during the years prior to treatment with haloperidol. To the authors' knowledge, no language disorder has been described in the literature which shows such a predictable and marked response to pharmacological treatment. The authors hypothesize that tic disorders in individuals with PDD may be a marker for a more positive response to dopamine antagonists like haloperidol.

UR - http://www.scopus.com/inward/record.url?scp=0022619237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022619237&partnerID=8YFLogxK

U2 - 10.1097/00004703-198604000-00001

DO - 10.1097/00004703-198604000-00001

M3 - Article

C2 - 3700663

AN - SCOPUS:0022619237

VL - 7

SP - 73

EP - 76

JO - Journal of Developmental and Behavioral Pediatrics

JF - Journal of Developmental and Behavioral Pediatrics

SN - 0196-206X

IS - 2

ER -